A large study found GLP-1 medications like semaglutide and tirzepatide are linked to 41% lower all-cause mortality risk versus metformin in prediabetes.
A large study found GLP-1 medications like semaglutide and tirzepatide are linked to 41% lower all-cause mortality risk versus metformin in prediabetes.
End of DispatchRead Original Coverage on foxnews